A detailed history of Kennedy Capital Management, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 16,058 shares of INCY stock, worth $1.16 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
16,058
Previous 13,362 20.18%
Holding current value
$1.16 Million
Previous $883,000 25.59%
% of portfolio
0.03%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$65.08 - $83.38 $175,455 - $224,792
2,696 Added 20.18%
16,058 $1.11 Million
Q3 2024

Nov 14, 2024

BUY
$57.33 - $68.61 $110,016 - $131,662
1,919 Added 16.77%
13,362 $883,000
Q2 2024

Aug 14, 2024

BUY
$51.18 - $63.75 $169,866 - $211,586
3,319 Added 40.85%
11,443 $693,000
Q1 2024

May 15, 2024

BUY
$56.55 - $66.59 $459,412 - $540,977
8,124 New
8,124 $462,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Kennedy Capital Management, Inc. Portfolio

Follow Kennedy Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.